Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$3.29 USD
-0.01 (-0.30%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $3.28 -0.01 (-0.30%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Athira Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -117.67 | -95.64 | -54.85 | -19.96 | -5.16 |
Depreciation/Amortization & Depletion | -0.45 | 0.42 | 0.97 | 0.54 | 0.26 |
Net Change from Assets/Liabilities | 6.53 | 1.94 | 6.16 | -6.45 | 0.68 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.84 | 20.81 | 4.62 | 1.75 | 0.51 |
Net Cash From Operating Activities | -100.75 | -72.47 | -43.10 | -24.11 | -3.71 |
Property & Equipment | -0.30 | -1.14 | -1.57 | -2.32 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 95.39 | 58.81 | -2.51 | -207.78 | 1.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 |
Net Cash from Investing Activities | 95.09 | 57.66 | -4.08 | -210.07 | 1.51 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.49 | 0.65 | 97.09 | 292.75 | 0.07 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.88 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Net Cash from Financing Activities | 0.49 | 0.65 | 97.09 | 292.75 | 0.95 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -5.17 | -14.15 | 49.91 | 58.57 | -1.26 |
Cash at Beginning of Period | 96.39 | 110.54 | 60.63 | 2.06 | 3.32 |
Cash at End of Period | 91.22 | 96.39 | 110.54 | 60.63 | 2.06 |
Diluted Net EPS | -3.09 | -2.53 | -1.49 | -1.67 | -1.45 |
Fiscal Year End for Athira Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -53.20 | -26.34 | -117.67 | -90.39 | -57.42 |
Depreciation/Amortization & Depletion | 0.05 | -0.02 | -0.45 | -0.41 | -0.26 |
Net Change from Assets/Liabilities | -1.00 | -2.19 | 6.53 | 7.78 | 1.19 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.01 | 2.74 | 10.84 | 8.55 | 6.01 |
Net Cash From Operating Activities | -48.13 | -25.80 | -100.75 | -74.46 | -50.48 |
Property & Equipment | -0.03 | -0.01 | -0.30 | -0.30 | -0.27 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 39.64 | 13.05 | 95.39 | 89.00 | 68.28 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 39.60 | 13.04 | 95.09 | 88.70 | 68.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.15 | 0.00 | 0.49 | 0.34 | 0.34 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.15 | 0.00 | 0.49 | 0.34 | 0.34 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -8.38 | -12.76 | -5.17 | 14.58 | 17.87 |
Cash at Beginning of Period | 91.22 | 91.22 | 96.39 | 96.39 | 96.39 |
Cash at End of Period | 82.83 | 78.45 | 91.22 | 110.97 | 114.26 |
Diluted Net EPS | -0.70 | -0.69 | -0.71 | -0.87 | -0.78 |